{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:50:22Z","timestamp":1789775422686,"version":"4.0.1"},"reference-count":0,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:p> The aim of this study was to compare epidemiological data with antibiotic susceptibility patterns, so as to characterize the risk of infection with a highly resistant Neisseria gonorrhoeae strain. N. gonorrhoeae strains isolated in Sweden from February 1998 through January 1999 were tested for antibiotic susceptibility. Epidemiological data were received from each clinician reporting a case of gonorrhoea and these data were linked to the N. gonorrhoeae strains. A total of 348 N. gonorrhoeae isolates, representing 89% of all Swedish cases diagnosed during the 12-month period, were tested for antibiotic susceptibility. Of all isolates, 24% were \u03b2-lactamase-producing, and 18% had decreased susceptibility to ciprofloxacin (MIC&gt;0.064 mg\/l). All isolates were fully susceptible to ceftriaxone and spectinomycin. More than 99% of the isolates were fully susceptible to azithromycin. The antibiotic susceptibility varied with the places where patients were exposed to infection. When exposed in Asia, 63% of the isolates showed reduced susceptibility to ciprofloxacin, compared with 0-8.5% of the isolates from patients exposed in other places (RR=8.5, P&lt;0.001). Ciprofloxacin cannot be recommended as the first choice of treatment if the place of exposure was in Asia. <\/jats:p>","DOI":"10.1258\/0956462021924730","type":"journal-article","created":{"date-parts":[[2003,1,17]],"date-time":"2003-01-17T02:47:37Z","timestamp":1042771657000},"page":"109-114","source":"Crossref","is-referenced-by-count":25,"title":["One year of <i>Neisseria gonorrhoeae<\/i> isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure"],"prefix":"10.1177","volume":"13","author":[{"given":"Torsten","family":"Berglund","sequence":"first","affiliation":[{"name":"Unit for Infectious Disease Epidemiology, Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden, and Unit for Infectious\r         Disease Epidemiology, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, \u00d6rebro Medical Centre Hospital, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Olc\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, \u00d6rebro Medical Centre Hospital, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Giesecke","sequence":"additional","affiliation":[{"name":"Unit for Infectious Disease Epidemiology, Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden, and Unit for Infectious\r         Disease Epidemiology, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Fredlund","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, \u00d6rebro Medical Centre Hospital, \u00d6rebro, Sweden and Unit for Infectious Disease Control,\r         Department of Clinical Microbiology and Immunology, \u00d6rebro Medical Centre Hospital, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2002,2,1]]},"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/0956462021924730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/0956462021924730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:39:10Z","timestamp":1741084750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/0956462021924730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2,1]]}},"alternative-id":["10.1258\/0956462021924730"],"URL":"https:\/\/doi.org\/10.1258\/0956462021924730","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}